Qure’s AMT-130 faces FDA efficacy doubts after 12-month data. QURE's upside now hinges on political pressure. Read here for ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
An informational industry analysis examining ingredient-level research, marketing positioning trends, regulatory context, and ...
In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...
News headlines often compress complex science into a simple storyline: If two things are happening at the same time, one must ...
A peer navigator intervention following a nonfatal opioid overdose in the emergency department does not significantly reduce ...
A key advantage of using RWD in a natural history study is gaining diverse and representative data. RWD covers broad patient populations, including those with comorbidities, various age groups, and ...
Agency staff "strongly recommended" a sham surgery-controlled trial be conducted before an approval filing, a stance one ...
Roivant Sciences Ltd. ( ROIV) TD Cowen 46th Annual Health Care Conference March 3, 2026 9:50 AM EST ...
The University of Warwick, which is setting up the Registry, plans to collect data for analysis from 500 AML patients at sites in 30 large metropolitan NHS hospitals across the UK by the end of this ...
4don MSN
Transcript: Rare Diseases
Transcript: Rare Diseases ...
Divergence in the post-progression interval suggests disparities may concentrate in subsequent-line therapy, surveillance, supportive care, or access to timely interventions outside trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results